Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-25T18:46:47.243Z Has data issue: false hasContentIssue false

Treatment of Rapid-Cycling Bipolar Disorder

Published online by Cambridge University Press:  07 November 2014

Robert M. Post
Affiliation:
Dr. Post is head of the Bipolar Collaborative Network in Chevy Chase, Maryland.

Abstract

Approximately 40% of bipolar patients experience rapid cycling, and half of these suffer from ultra-rapid or ultradian cycling. These patterns are also common in children. Rapid-cycling bipolar disorder is difficult to bring to remission and often requires treatment with four or more classes of psychotropic medications. Lithium, even in combination with anticonvulsants or antidepressants, is often associated with residual episodic depressions. Concerns with adjunctive antidepressant treatment include their low response and remission rates and their tendency to cause switch into mania. Atypical antipsychotics and selected agents within the anticonvulsant class are becoming increasingly important in the treatment of rapid cycling. In the absence of clear treatment guidelines, the use and sequencing of drugs in complex combination treatment remains exploratory, but should be individualized based on careful prospective mood charting by the patient. Use of several drugs below their side-effect thresholds may prevent certain side effects. In children, long-term safety considerations are particularly important in the absence of a strong controlled clinical trials database.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dunner, DL, Fieve, RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 1974;30:229233.CrossRefGoogle ScholarPubMed
2.Leverich, GS, Post, RM. Life charting of affective disorders. CNS Spectr. 1998;3:2137.CrossRefGoogle Scholar
3.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
4.Robbins, GK, De Gruttola, V, Shafer, RW, et al.Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med. 2003;349:22932303.CrossRefGoogle ScholarPubMed
5.Calabrese, JR, Shelton, M, Rapport, D, et al.A 20-month, double-blind, maintenance study of lithium vs. divalproex monotherapy in bipolar I and II disorder accompanied by rapid cycling. Bipolar Disord. 2003;5(suppl 1):38.Google Scholar